Vaccine induced herd immunity for control of respiratory syncytial virus disease in a low-income country setting

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Kinyanjui, Timothy M ^a   House, Thomas A ^a,b   Kiti, Moses C ^c   Cane, Patricia A ^d   Nokes, David J ^c,e   Medley, Graham F ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; HERD IMMUNITY; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; MATHEMATICAL MODEL; MAXIMUM LIKELIHOOD METHOD; PUBLIC HEALTH; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VACCINATION; ADOLESCENT; ADULT; AGE; AGED; BIOLOGICAL MODEL; CHILD; COMPUTER SIMULATION; HOSPITALIZATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; INFANT; KENYA; MIDDLE AGED; POVERTY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; STATISTICAL MODEL; YOUNG ADULT;

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; HOSPITALIZATION; HUMANS; IMMUNITY, HERD; INFANT; KENYA; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; POVERTY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINATION; YOUNG ADULT;

EID: 84946606518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138018     Document Type: Article

References (47)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and metaanalysis. Lancet. 2010; 375(9725):1545-55. Epub 2010/04/20. doi: 10.1016/s0140-6736(10)60206-1 PMID: 20399493; PubMed Central PMCID: PMC2864404.
2. Brearey SP, Smyth RL. Pathogenesis of RSV in children In: Cane PA, editor. Respiratory syncytial virus. Perspectives in Medical Virology. First ed. Amsterdam, The Netherlends: Elsevier; 2007. p. 141-62.
3. Collins PL, Murphy BR. Vaccines against human respiratory syncytial virus. In: Cane PA, editor. Respiratory syncytial virus. Perspectives in Medical Virology. Frist ed. Amsterdam, The Netherlands: Elsevier; 2007. p. 233-77.
4. Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis. 2005; 191(7):1093-104. Epub 2005/03/05. doi: 10.1086/427813 PMID: 15747245.
5. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr., Boyce TG, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis. 2000; 182(5):1331-42. Epub 2000/09/30. doi: 10.1086/315859 PMID: 11010838.
6. http://sites.path.org/vaccinedevelopment/files/2013/09/RSV-Vaccine-Snapshot-24Sep13.pdf.
7. Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013; 31 Suppl 2:B209-15. Epub 2013/04/26. doi: 10.1016/j.vaccine.2012.11.106 PMID: 23598484; PubMed Central PMCID: PMC3919153.
8. Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, et al. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine. 2007; 25(42):7372-8. Epub 2007/09/18. doi: 10.1016/j.vaccine.2007.08.014 PMID: 17868959; PubMed Central PMCID: PMC2760483.
9. Bernstein DI, Malkin E, Abughali N, Falloon J, Yi T, Dubovsky F. Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children. The Pediatric infectious disease journal. 2012; 31(2):109-14. Epub 2011/09/20. doi: 10.1097/INF.0b013e31823386f1 PMID: 21926667.
10. Malkin E, Yogev R, Abughali N, Sliman J, Wang CK, Zuo F, et al. Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. PloS one. 2013; 8(10):e77104. Epub 2013/11/10. doi: 10.1371/journal.pone.0077104 PMID: 24204744; PubMed Central PMCID: PMCPmc3812203.
11. Nokes DJ, Ngama M, Bett A, Abwao J, Munywoki P, English M, et al. Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis. 2009; 49(9):1341-9. Epub 2009/10/01. doi: 10.1086/606055 PMID: 19788358; PubMed Central PMCID: PMC2762474.
12. Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, et al. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis. 2008; 46(1):50-7. Epub 2008/01/04. doi: 10.1086/524019 PMID: 18171213; PubMed Central PMCID: PMC2358944.
13. Graham BS. Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics. J Infect Dis. 2014; 209(11):1679-81. Epub 2014/02/14. doi: 10.1093/infdis/jiu075 PMID: 24523511; PubMed Central PMCID: PMC4038969.
14. Ohuma EO, Okiro EA, Ochola R, Sande CJ, Cane PA, Medley GF, et al. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol. 2012; 176(9):794-802. Epub 2012/10/13. doi: 10.1093/aje/kws257 PMID: 23059788; PubMed Central PMCID: PMC3481264.
15. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas GR Jr. Respiratory syncytial virus infections within families. N Engl J Med. 1976; 294(8):414-9. Epub 1976/02/19. doi: 10.1056/nejm197602192940803 PMID: 173995.
16. Munywoki PK, Koech DC, Agoti CN, Lewa C, Cane PA, Medley GF, et al. The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya. J Infect Dis. 2014; 209 (11):1685-92. Epub 2013/12/25. doi: 10.1093/infdis/jit828 PMID: 24367040; PubMed Central PMCID: PMC4017365.
17. Keeling MJ, White PJ. Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great Britain. J R Soc Interface. 2011; 8(58):661-70. Epub 2010/10/15. doi: 10.1098/rsif.2010.0474 PMID: 20943682; PubMed Central PMCID: PMC3061093.
18. Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science. 2009; 325(5948):1705-8. Epub 2009/08/22. doi: 10.1126/science.1175570 PMID: 19696313.
19. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010; 330(6006):982-5. Epub 2010/11/13. doi: 10.1126/science.1194134 PMID: 21071671.
20. Agoti CN, Mwihuri AG, Sande CJ, Onyango CO, Medley GF, Cane PA, et al. Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis. 2012; 206(10):1532-41. Epub 2012/09/12. doi: 10.1093/infdis/jis570 PMID: 22966119; PubMed Central PMCID: PMC3475639.
21. Scott PD, Ochola R, Ngama M, Okiro EA, James Nokes D, Medley GF, et al. Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya. J Infect Dis. 2006; 193:59-67. PMID: 16323133
22. Henderson FW, Collier AM, Clyde WA Jr., Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979; 300 (10):530-4. Epub 1979/03/08. doi: 10.1056/nejm197903083001004 PMID: 763253.
23. Okiro EA, White LJ, Ngama M, Cane PA, Medley GF, Nokes DJ. Duration of shedding of respiratory syncytial virus in a community study of Kenyan children. BMC Infect Dis. 2010; 10:15. doi: 10.1186/1471-2334-10-15 PMID: 20096106
24. Waris M, Maurice OM, Mufson A, Ruuskanen O, Halonen P. Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus. Journal of Medical Virology. 1992; 38:111-6. PMID: 1460457
25. Inc M. MATLAB. 7.7.0 ed. Natick: Mathworks; 2014.
26. Anderson RM, May RM. Spatial, temporal, and genetic heterogeneity in host populations and the design of immunization programmes. IMA J Math Appl Med Biol. 1984; 1(3):233-66. Epub 1984/01/01. PMID: 6600104.
27. Schenzle D. Control of Virus Transmission in Age-Structured Populations. In: Capasso V, Grosso E, Paveri-Fontana SL, editors. Mathematics in Biology and Medicine. Lecture Notes in Biomathematics. 57: Springer Berlin Heidelberg; 1985. p. 171-8.
28. Kiti MC, Kinyanjui TM, Koech DC, Munywoki PK, Medley GF, Nokes DJ. Quantifying age-related rates of social contact using diaries in a rural coastal population of kenya. PloS one. 2014; 9(8):e104786. Epub 2014/08/16. doi: 10.1371/journal.pone.0104786 PMID: 25127257; PubMed Central PMCID: PMC4134222.
29. Scott JAG, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). International journal of epidemiology. 2012; 41:650-7. doi: 10.1093/ije/dys062 PMID: 22544844.
30. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol. 2006; 164:936-44. PMID: 16968863
31. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome. Science. 2003; 300:1966-70. PMID: 12766207
32. McKay MD, Beckman R, Conover W. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics. 1979; 21:239-45.
33. Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. 2007:366.
34. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF. The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection. Epidemiol Infect. 2005; 133(2):279-89. Epub 2005/04/09. PMID: 15816153; PubMed Central PMCID: PMC2870247.
35. McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect. 1988; 100(3):419-42. Epub 1988/06/01. PMID: 3378585; PubMed Central PMCID: PMC2249353.
36. Grenfell BT, Bjornstad ON, Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature. 2001; 414(6865):716-23. Epub 2001/12/14. doi: 10.1038/414716a PMID: 11742391.
37. White LJ, Mandl JN, Gomes MG, Bodley-Tickell AT, Cane PA, Perez-Brena P, et al. Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models. Math Biosci. 2007; 209(1):222-39. Epub 2007/03/06. doi: 10.1016/j.mbs.2006.08.018 PMID: 17335858; PubMed Central PMCID: PMC3724053.
38. Gomes MG, White LJ, Medley GF. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol. 2004; 228(4):539-49. Epub 2004/06/05. doi: 10.1016/j.jtbi.2004.02.015 PMID: 15178201.
39. Morris SE, Pitzer VE, Viboud C, Metcalf CJ, Bjornstad ON, Grenfell BT. Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics. J R Soc Interface. 2015; 12 (104):20141245. doi: 10.1098/rsif.2014.1245 PMID: 25589567; PubMed Central PMCID: PMC4345488.
40. Pitzer VE, Viboud C, Alonso WJ, Wilcox T, Metcalf CJ, Steiner CA, et al. Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States. PLoS Pathog. 2015; 11(1): e1004591. doi: 10.1371/journal.ppat.1004591 PMID: 25569275; PubMed Central PMCID: PMC4287610.
41. Poletti P, Merler S, Ajelli M, Manfredi P, Munywoki PK, Nokes D, et al. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings. BMC Med. 2015; 13:49. doi: 10.1186/s12916-015-0283-x PMID: 25857701; PubMed Central PMCID: PMC4372170.
42. Acedo L, Diez-Domingo J, Morano JA, Villanueva RJ. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010; 138(6):853-60. doi: 10.1017/S0950268809991373 PMID: 20003640.
43. Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics. 2007; 119(1): e22-9. Epub 2007/01/04. doi: 10.1542/peds.2006-1572 PMID: 17200247.
44. Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making. 2003; 23(1):76-82. Epub 2003/02/14. PMID: 12583457.
45. Klepac P, Laxminarayan R, Grenfell BT. Synthesizing epidemiological and economic optima for control of immunizing infections. Proc Natl Acad Sci U S A. 2011; 108(34):14366-70. Epub 2011/08/10. doi: 10.1073/pnas.1101694108 PMID: 21825129; PubMed Central PMCID: PMC3161560.
46. Fumanelli L, Ajelli M, Manfredi P, Vespignani A, Merler S. Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread. PLoS Comput Biol. 2012; 8(9): e1002673. Epub 2012/10/03. doi: 10.1371/journal.pcbi.1002673 PMID: 23028275; PubMed Central PMCID: PMC3441445.
47. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):e74. Epub 2008/03/28. doi: 10.1371/journal.pmed.0050074 PMID: 18366252; PubMed Central PMCID: PMC2270306.